Effect of burn injury on glucose turnover in guinea pigs. 1977

R R Wolfe, and H I Miller, and D Elahi, and J J Spitzer

Using our guinea pig model, we found the rate of appearance of glucose was elevated during the three phases following burn injury: the burn shock phase, the hypermetabolic phase and the septic phase. The rate of disappearance of glucose initially was not elevated, resulting in hyperglycemia during burn shock, but eventually, the rate of disappearance of glucose increased to the same extent as the rate of appearance of glucose. During the hypermetabolic and septic phases, the glucose turnover rate was elevated, but the plasma glucose concentration was normal. Glucose turnover was poorly correlated with total body oxygen consumption, suggesting that not all of the increased turnover of glucose was due to increased glucose oxidation.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D010101 Oxygen Consumption The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346) Consumption, Oxygen,Consumptions, Oxygen,Oxygen Consumptions
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002056 Burns Injuries to tissues caused by contact with heat, steam, chemicals (BURNS, CHEMICAL), electricity (BURNS, ELECTRIC), or the like. Burn
D002302 Cardiac Output The volume of BLOOD passing through the HEART per unit of time. It is usually expressed as liters (volume) per minute so as not to be confused with STROKE VOLUME (volume per beat). Cardiac Outputs,Output, Cardiac,Outputs, Cardiac
D003345 Corticosterone An adrenocortical steroid that has modest but significant activities as a mineralocorticoid and a glucocorticoid. (From Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1437)
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor

Related Publications

R R Wolfe, and H I Miller, and D Elahi, and J J Spitzer
August 1977, The American journal of physiology,
R R Wolfe, and H I Miller, and D Elahi, and J J Spitzer
July 1980, The Journal of nutrition,
R R Wolfe, and H I Miller, and D Elahi, and J J Spitzer
January 1984, Circulatory shock,
R R Wolfe, and H I Miller, and D Elahi, and J J Spitzer
January 1981, Circulatory shock,
R R Wolfe, and H I Miller, and D Elahi, and J J Spitzer
January 1973, Physiologia Bohemoslovaca,
R R Wolfe, and H I Miller, and D Elahi, and J J Spitzer
January 1985, Biology of the neonate,
R R Wolfe, and H I Miller, and D Elahi, and J J Spitzer
March 1993, The Journal of trauma,
R R Wolfe, and H I Miller, and D Elahi, and J J Spitzer
October 1999, Shock (Augusta, Ga.),
R R Wolfe, and H I Miller, and D Elahi, and J J Spitzer
January 1995, The American journal of physiology,
R R Wolfe, and H I Miller, and D Elahi, and J J Spitzer
December 1978, The Journal of trauma,
Copied contents to your clipboard!